Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

1,955.00INR
23 May 2018
Change (% chg)

Rs-58.75 (-2.92%)
Prev Close
Rs2,013.75
Open
Rs1,989.95
Day's High
Rs1,992.75
Day's Low
Rs1,936.35
Volume
46,313
Avg. Vol
63,028
52-wk High
Rs2,788.00
52-wk Low
Rs1,888.00

Select another date:

Wed, May 23 2018

BUZZ-India's Dr. Reddy's Laboratories falls on bleak Q4 show

** Indian generic drugmaker Dr. Reddy's Laboratories Ltd falls as much as 3.2 pct to 1,945 rupees

Sensex, Nifty close slightly higher; SBI, Dr. Reddy's gain

Indian shares ended slightly higher on Tuesday, driven by gains in Dr. Reddy's Laboratories Ltd and State Bank of India (SBI) following their quarterly results.

Indian shares close slightly higher; SBI, Dr.Reddy's gain on Q4 results

May 22 Indian shares ended slightly higher on Tuesday, driven by gains in Dr. Reddy's Laboratories Ltd and State Bank of India (SBI) following their quarterly results.

Dr. Reddy's fourth-quarter profit falls 19 percent on U.S. headwinds

Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 19 percent drop in quarterly net profit on Tuesday, missing analysts' estimates, pulled down by headwinds in the U.S. market.

UPDATE 1-India's Dr. Reddy's Q4 profit falls 19 pct on U.S. headwinds

May 22 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 19 percent drop in quarterly net profit on Tuesday, missing analysts' estimates, pulled down by headwinds in the U.S. market.

CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates

May 22 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted an about 19 percent fall in quarterly net profit, missing estimates, hurt by headwinds in the U.S. market.

BRIEF-India's Dr.Reddy's Labs March Qtr Consol Profit Down 19.4 Pct

* MARCH QUARTER CONSOL NET SALES 34.46 BILLION RUPEES VERSUS 34.99 BILLION RUPEES LAST YEAR

BRIEF-India's Dr.Reddy's Labs March Qtr Consol Profit Down 3.3 Pct

* CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 3.59 BILLION RUPEES

BRIEF-Dr.Reddy's Labs Gets EIR From USFDA For API Mirfield Plant, UK

* GETS ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR API MIRFIELD PLANT, UK Source text for Eikon: Further company coverage:

BRIEF-Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico

* SAYS GETS EIR FROM US FDA FOR API CUERNAVACA PLANT IN MEXICO Source text: https://bit.ly/2H9URmM Further company coverage:

Select another date: